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Abstract
CD40 plays important roles in cell-mediated and humoral immune responses. In this study, we
explored mechanisms underlying lipopolysaccharide (LPS)-induced CD40 expression in purified
human peripheral blood monocytic cells (PBMCs) from healthy volunteers. Exposure to LPS induced
increases in CD40 mRNA and protein expression on PBMCs. LPS stimulation caused IκBα
degradation. Inhibition of NFκB activation abrogated LPS-induced CD40 expression. LPS
stimulation also resulted in phosphorylation of mitogen-activated protein kinases, however, only Jun
N-terminal kinase (JNK) was partially involved in LPS-induced CD40 expression. In addition, LPS
exposure resulted in elevated interferon γ (IFNγ) levels in the medium of PBMCs. Neutralization of
IFNγ and IFNγ receptor using specific antibodies blocked LPS-induced CD40 expression by 44%
and 37%, respectively. In summary, LPS induced CD40 expression on human PBMCs through
activation of NFκB and JNK, and partially through the induction of IFNγproduction.
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CD40 is a member of the tumor necrosis factor (TNF) receptor family and is expressed on a
variety of cell types, such as monocytes, B cells, macrophages, basophils, eosinophils, dendritic
cells and endothelial cells [1]. The CD40 molecule is a phosphorylated glycoprotein with the
structure of a typical type I transmembrane protein that is composed of 277 amino acids with
a 193 amino acid extracellular domain, a 22 amino acid transmembrane domain, and a 62 amino
acid intracellular tail [2]. Ligation of CD40 by its ligand, CD154, activates numerous signaling
pathways leading to changes in gene expression and function. These signaling pathways
include nuclear factor κB (NFκB), mitogen-activated protein kinases (MAPKs), TNF receptor-
associated factor proteins, phosphoinositide 3-kinase (PI3K), and the janus kinase/signal
transducer and activator of transcription (JAK/STAT) pathway [3]. Signaling through CD40
up-regulates the expression of cell surface molecules such as class II major histocompatibility
complex (MHC II), CD80, and CD86, adhesion molecules, secretion of cytokines and
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chemokines such as interleukin-1 (IL-1), IL-6, IL-10, TNFα, and promotes prothrombotic
activities and immunoglobulin class-switching to IgE [4,5]. Thus, CD40 is not only critical in
mediating normal immune responses, it also participates in a wide range of immune responses
that have been associated with a variety of pathogenic processes in chronic inflammatory
diseases that include asthma, autoimmune diseases, and atherosclerosis [6,7].
In comparison to studies of CD40 signaling and function, less is known about the mechanisms
that regulate human CD40 gene expression [4]. The CD40 gene is mapped to chromosome
20q11-q13 and expressed as a single 1.5 kb mRNA species. The CD40 promoter is a TATA-
less promoter that contains three potential interferon (IFN) gamma activated sequence (GAS)
elements. Other potentially relevant cis-regulatory elements in the human CD40 5′-flanking
region are consensus sequences for NFκB, Ets family, activator protein-1 (AP-1), c-Myc, and
Sp1 [8]. In mouse macrophages, transcription factors, such as NFκB, STAT-1α, PU.1, and Spi-
B, have been shown to mediate CD40 induction after endotoxin or cytokine stimulation [4,9,
10]. The human CD40 gene shares 62% amino acid identity in the complete coding sequence
with the mouse CD40 gene [1,11]. A previous study has shown that coarse, fine, and ultrafine
air pollution particles increased immune costimulatory receptors including CD40, CD80, and
CD86, and MHC class II molecules (HLA-DR) on human blood-derived monocytic cells
[12]. Ensuing studies in our laboratory have indicated that LPS was an important component
on air particles and responsible for particle-induced immune responses. The present study
aimed to uncover the events regulating LPS-induced CD40 expression in normal human
peripheral blood monocytic cells (PBMCs). Human PBMCs (composed of 93% monocytes
and 7% lymphocytes) were isolated from healthy volunteers. We observed that LPS induced




LPS (Escherichia coli 0127:B8 ) was purchased from Sigma-Aldrich Co. (St. Louis, MO).
SDS-PAGE supplies such as molecular mass standards and buffers were obtained from Bio-
Rad (Richmond, CA). The mouse anti-human CD40-phycoerythrin (PE) and IgG1-PE
antibodies were purchased from Beckman Coulter-Immunotech (Marseille, France). IFNγ
neutralizing antibodies and ELISA assay kit were purchased from eBioscience (San Diego,
CA). IFNγ receptor neutralizing antibody was obtained from R&D Systems, Inc. (Minneapolis,
MN). Phospho-specific and pan antibodies against ERK, JNK, and p38, and IκBα antibody
were purchased from Cell Signaling Technology (Beverly, MA). β-actin antibody was
purchased from USBiological (Swampscott, MA). Horseradish peroxidase (HRP)-conjugated
goat anti-rabbit and goat anti-mouse IgG were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA). Polymyxin B, the ERK kinase inhibitor PD98059, the p38 kinase inhibitor
SB203580, the JNK inhibitor SP600125, and the NFκB activation inhibitor Bay11-7082 were
purchased from EMD Biosciences (San Diego, CA).
PBMC isolation and cell culture
PBMCs were isolated from heparinized peripheral blood from healthy volunteers using
Lymphoprep (Nycomed Pharma AS, Oslo, Norway) and further purified using a discontinuous
35/51% percoll gradient (Sigma, St Louis, MO) yielding monocytes of 93% purity, as described
previously [13]. The remaining 7% cells of these PBMCs were microscopically identified as
lymphocytes with Hema 3 stain. PBMCs were incubated in RPMI 1640 medium containing
10% fetal bovine serum and 100 μg/ml penicillin/streptomycin at 37 °C in 5% CO2. Cells were
incubated in ultra low attachment plates (Corning Inc., Corning, NY) or polypropylene tubes
for LPS stimulation studies.
Wu et al. Page 2














PBMCs treated with LPS were washed twice with cold phosphate-buffered saline (PBS), and
then lysed in RIPA buffer (1× PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS,
and protease inhibitors: 20 μg/ml leupeptin, 20 μg/ml aprotinin, 0.5 mM phenylmethylsulfonyl
fluoride, 200 μM sodium orthovanadate, and 20 mM sodium fluoride). Supernatants of cell
lysates were subjected to SDS-PAGE, as described before [14]. Proteins were transferred onto
nitrocellulose membrane. Membrane was blocked with 5% nonfat milk, washed briefly,
incubated with primary antibody at 4°C overnight, followed by incubating with corresponding
HRP-conjugated secondary antibody for 1 h at room temperature. Immunoblot images were
detected using chemiluminescence reagents and the Gene Gynome Imaging System (Syngene,
Frederick, MD).
Flow cytometry
3×105 PBMCs were used for measurement of CD40 protein expression. Flow cytometry was
performed with a FACSORT (Becton Dickinson, Miami, FL) using an Argon-ion laser
(wavelength 488nm) [15]. The FACSORT was calibrated with Calibrite beads before each use,
and 10,000 events were counted for all sample runs. PE-conjugated non-specific antibody of
the same isotype as the receptor antibody was used as control to establish background
fluorescence and non-specific antibody binding. The mean fluorescence intensity (MFI) of the
cells stained with control antibody was subtracted from the MFI of cells stained with receptor
antibody to provide a measure of receptor-specific MFI. Relative cell size and density/
granularity were quantified by analyzing light-scatter properties using Cell Quest software
(Becton Dickinson), namely forward scatter for cell size and side scatter for density/granularity.
Real-time reverse transcriptase/polymerase chain reaction (RT-PCR)
1×106 blood PBMCs were exposed to LPS. Cells were washed with ice-cold PBS and then
lysed with TRIZOL reagent (Invitrogen Corporation, Carlsbad, CA). Total RNA was isolated
according to manufacturer-provided instructions. RNA (200ng) was reverse transcribed into
cDNA. Quantitative PCR was performed using Platinum Quantitative PCR SuperMix-UDG
(Invitrogen Corporation, Carlsbad, CA) and an ABI Prism 7700 sequence detector (Applied
Biosystems, Foster City, CA). mRNA levels of CD40 and IFNγ were normalized to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. Relative amounts of CD40 or
IFNγ and GAPDH mRNA were based on standard curves prepared by serial dilution of cDNA
from human airway epithelial cells. The oligonucleotide primers and probes were purchased
from Applied Biosystems (Foster City, CA).
Enzyme linked immunosorbent assay (ELISA)
5×105 PBMCs were treated with LPS. Supernatants were collected by centrifugation.
Measurement of released IFNγ from PBMC culture with ELISA was conducted following the
manufacturer’s instructions.
Statistics
Differences in CD40 expression or cytokine production were evaluated using nonparametric
paired t tests with the overall α level set at 0.05. Data were presented as means ± SEMs.
Results and Discussion
LPS exposure increases CD40 expression on the monocytes of human PBMCs
CD40 expression is observed in a wide range of cells, including macrophages and dendritic
cells. In this present study, CD40 expression was determined on freshly isolated human PBMCs
at both mRNA and cell surface protein levels. As shown in Fig.1A, PBMCs exposed to 1 ng/
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ml LPS developed increased CD40 mRNA expression at 4 h and a further increase at 8 h of
exposure. Exposure of PBMCs to 0.001–1000 ng/ml LPS for 24 h induced a dose-dependent
increase in CD40 cell surface protein expression (Fig.1B). Stimulation of PBMCs with 1 ng/
ml LPS for 6, 12, and 24 h caused a time-dependent increase in CD40 protein expression that
became significant at 12 h (Fig.1C). From flow analysis (gated on lymphocytes) we observed
little increase of CD40 protein expression on the 7% residual lymphocytes. To confirm this
with a larger number of cells, lymphocytes (99% purity) were collected through the same
procedure for PBMC isolation and exposed to 1 ng/ml LPS for 24 h. It was found that LPS did
not induce CD40 cell surface expression on these lymphocytes (data not shown). These data
suggested that LPS-induced CD40 expression only occurred on the monocytes and not on the
residual lymphocytes of PBMCs.
Activation of NFκB is required for LPS-induced CD40 expression on PBMCs
Because of the importance of NFκB activation in LPS-induced signaling [16,17], the
involvement of NFκB in LPS-induced CD40 gene transcription was investigated in this study.
NFκB transcription factors are present in the cytoplasm in an inactive state, complexed with
inhibitory IκB proteins, which cover the nuclear localization structures of NFκB.
Phosphorylation of cytoplasmic IκBα at two conserved NH2-terminal serine residues (Ser32
and Ser36) and its subsequent proteosomal degradation by the 26S proteasome allows NFκB
nuclear translocation and activation of NFκB-dependent transcriptional activity [18]. NFκB
has been proposed as an important transcription factor in LPS-induced CD40 expression in
murine macrophages and microglia [9]. Analysis of the CD40 promoter demonstrates that
NFκB regulatory elements is conserved between the human and mouse CD40 promoters.
Within the CD40 promoter, there are four NFκB sites that are designated as dκB, mκB,
m2κB, and pκB [19]. To determine whether NFκB was activated by LPS stimulation in our
system and to examine its involvement in LPS-induced CD40 expression, IκBα levels were
determined in PBMCs exposed to LPS. As shown in Fig. 2A, LPS (1 ng/ml) induced a rapid
time-dependent reduction of IκBα protein, indicative of NFκB activation. Recent studies have
investigated the upstream signaling pathways responsible for LPS-induced NFκB activation.
It was shown that LPS could induce NFκB activation through transforming growth factor β
(TGFβ)-activated kinase (TAK1), which was a member of the mitogen-activated protein kinase
kinase kinase (MAPKKK) family [16]. PI3K was also demonstrated to mediate LPS-induced
NFκB activation through induction of p65 phosphorylation[20].
To investigate whether NFκB activation was involved in LPS-induced CD40 expression on
human monocytes, we pretreated PBMCs with the potent inhibitor of NFκB activation
Bay11-7082 [21] prior to LPS addition. PBMCs were pretreated with 2 μM Bay11-7082 for
30 min before addition of 1 ng/ml LPS. At this dose Bay11-7082 was not cytotoxic to PBMCs.
As shown in Fig. 2B, Bay11-7082 strongly suppressed LPS-induced CD40 expression on
monocytes at 24 h. Thus, NFκB activation was required for LPS-induced CD40 expression on
the monocytes of human PBMCs as in murine macrophages and microglia [3,9].
Signaling through CD40 is known to activate the NFκB pathway, and in this study we have
demonstrated that CD40 expression is also regulated by NFκB. Taken together, the
upregulation of CD40 expression might be regulated through a positive feedback mechanism
using this CD40/NFκB activation pathway.
Involvement of JNK in LPS-induced CD40 expression
The MAPKs are generally expressed in all cell types. Three groups of MAPKs have been
identified inmammals: the extracellular signal–regulated protein kinases (ERKs), the c-Jun N-
terminal kinases (JNKs), and the p38 stress-activated protein kinases. The ERK pathway
appears mainly to respond to mitogens and growth factors that regulate cell proliferation and
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differentiation. The JNK and p38 pathways are predominantly activated by stress, such as
osmotic changes and heat shock, but also by inflammatory cytokines. LPS is a potent activator
of all three MAPKs [22]. Previous studies have demonstrated that MAPK-mediated LPS effects
were cell type specific and depended on the surface molecules studied [23–25]. In this study,
we examined the effect of LPS on activities of MAPKs and their involvement in CD40
expression on PBMCs. Activation of MAPKs occurs through phosphorylation of specific
residues of these kinases. Thus, phosphorylation of MAPKs was measured using phospho-
specific antibodies against JNK (Thr183/Tyr185), p38 (Thr180/Tyr182), and ERK (Thr202/
Tyr204), respectively. PBMCs were exposed to 1 ng/ml LPS for 15, 30, 60, and 120 min. As
shown in Fig. 3, LPS stimulation resulted in a rapid increase in phosphorylation of JNK, p38,
and ERK in PBMCs, reaching a maximum for JNK and ERK at 30 min whereas
phosphorylation of p38 continued to increase throughout the period of observation.
To determine whether activated MAPKs participated in LPS-induced CD40 expression on
blood monocytes, we used selective kinase inhibitors, 20 μM PD98059, SP600125, and
SB203580, which specifically inhibited ERK kinase, JNK, and p38 activities, respectively, to
pretreat PBMCs for 30 min prior to LPS stimulation (1 ng/ml) for 24 h. It was found that only
the JNK inhibitor SP600125 partially inhibited LPS-induced CD40 expression on the
monocytes (Fig. 3D). Whether JNK modulates CD40 gene transcription through activation of
transcription factors such as AP-1 in the CD40 promoter remains to be investigated.
IFNγ released from the residual lymphocytes of PBMCs is partially involved in LPS-induced
CD40 expression
Since 7% lymphocytes were presented in the PBMCs and lymphocytes were well-known for
their production of IFNγ [26], a potent CD40 inducer [19], we next used ELISA to determine
the levels of IFNγ, in the medium of PBMCs exposed to 0.01, 1, and 100 ng/ml LPS for 24 h.
As shown in Fig. 4A, LPS stimulation induced dose-dependent increase in IFNγ protein levels
in the medium of PBMCs. Exposure of PBMCs to 1 ng/ml LPS increased IFNγ protein
production in a time-dependent fashion (Fig. 4B). In addition, IFNγ mRNA expression was
also determined in PBMCs treated with 1 ng/ml LPS for 8 h (Fig. 4C), which showed that
IFNγ mRNA levels were increased by LPS stimulation. Since freshly purified human
monocytes do not produce detectable IFN activity when stimulated with LPS [27,28], the
IFNγ proteins detected in the culture medium must be secreted from the residual 7%
lymphocytes. We confirmed this using a human monocytic cell line (THP-1) where no IFNγ
production after LPS treatment was observed (data not shown).
IFNγ is a dimerized soluble cytokine that is the only member of the type II class of IFN [29].
The major biological responses to IFNγ are mediated through the JAK/STAT pathway [30].
Seven mammalian STATs have been identified thus far, and STAT-1 is the major transcription
factor in the IFNγ signal transduction pathway [30]. Binding of IFNγ to its receptor induces a
series of events, which ultimately results in tyrosine phosphorylation of STAT-1, followed by
homodimerization, nuclear translocation, and binding to GAS elements in the promoter regions
of IFNγ-inducible genes. To ascertain the magnitude of the role played by IFNγ in LPS-induced
CD40 expression, neutralizing antibodies against human IFNγ (anti-IFNγ) or IFNγ receptors
(anti-IFNγR) were employed to pretreat PBMCs. To first characterize the specificities of these
two neutralizing antibodies, PBMCs were pretreated with 20 μg/ml anti-IFNγ and anti-
IFNγR, respectively, prior to addition of 500 pg/ml recombinant human IFNγ. It was shown
that anti-IFNγ and anti-IFNγR significantly inhibited IFNγ-induced CD40 expression on
PBMCs by 85% and 82%, respectively, at 24 h. Then, PBMCs were pre-incubated with 20
μg/ml IgG (vehicle), anti-IFNγ, or anti-IFNγ receptor (IFNγR) at 37ºC for 2 h prior to
stimulation with 1 ng/ml LPS for 24 h. We observed that anti-IFNγ and anti-IFNγR inhibited
LPS-induced CD40 expression by 44% and 37%, respectively (Fig. 4D). Therefore, these data
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indicated that IFNγ released from the lymphocytes of PBMCs was only partially responsible
for LPS-induced CD40 expression. Additional studies have demonstrated that both NFκB and
JNK were required for LPS-induced IFNγ production (data not shown). And the interaction
between lymphocytes and monocytes in PBMC culture facilitated LPS-induced IFNγ
production from the residual lymphocytes of PBMCs since the same number of isolated pure
lymphocytes as in PBMCs produced less IFNγ after LPS stimulation.
In summary, LPS induces CD40 expression on human peripheral blood monocytes through
activation of NFκB and JNK, and through IFNγ production by lymphocytes.
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Fig 1. LPS exposure results in increase in CD40 expression on human monocytes
A, Human PBMCs were treated with 1 ng/ml LPS for 4 and 8 h. Cells were then lysed with
TRIZOL reagent. RNA was extracted and reverse transcribed before further analysis of CD40
mRNA expression using quantitative PCR. CD40 mRNA levels were normalized using the
expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. B, Human
PBMCs were treated with 0.001–1000 ng/ml LPS for 24 h. C, PBMCs were incubated with 1
ng/ml LPS for 6, 12, and 24 h. CD40 protein expression was measured with flow cytometry
using isotype and anti-CD40 antibodies, respectively, as described in Materials and Methods.
*P<0.05, compared to control (Ct).
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Fig 2. NFκB activation is required for LPS-induced CD40 expression
A, PBMCs were treated with 1 ng/ml LPS for 0, 15, 30, 60, and 120 min. IκBα protein levels
were measured with Western blotting using anti-IκBα antibody. B, PBMCs were pretreated
with DMSO or 2 μM Bay11-7082 for 30 min prior to 1 ng/ml LPS stimulation for 24 h,
respectively. CD40 expression (MFI) was measured with flow cytometry. * P<0.05, compared
to vehicle (DMSO) LPS.
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Fig 3. JNK is partially involved in LPS-induced CD40 expression
PBMCs were stimulated with 1 ng/ml LPS for 15–120 min. Cells were lysed with RIPA buffer.
Supernatants of cell lysates were subjected to SDS-PAGE and immunoblotting.
Phosphorylated JNK (A), p38 (B), and ERK (C) kinases were detected using phospho-specific
antibodies. D, PBMCs were pretreated with DMSO (vehicle), 20 μM SB203580, 20 μM
SP600125, or 20 μM PD98059 for 30 min, respectively, prior to 1 ng/ml LPS treatment for 24
h. CD40 expression was determined using flow cytometry. * P<0.05, compared to vehicle
(DMSO) LPS. Data shown are representative of three separate experiments.
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Fig 4. LPS-induced IFNγ production is involved in CD40 expression
A, PBMCs were treated with 0.01, 1, and 100 ng/ml LPS for 24 h, respectively. Supernatants
of cell media were collected for measurement of IFNγ protein with ELISA. *P<0.05, compared
to control (Ct). B, PBMCs were treated with 1 ng/ml LPS for 8 and 24 h, respectively.
Supernatants of cell media were collected for measurement of IFNγ protein with ELISA.
Increase in IFNγ protein release was expressed as fold over control. *P<0.05, compared to
control (Ct) at the same time point. C, PBMCs were treated with 1 ng/ml LPS for 8 h prior to
lysis with TRIZOL reagent. RNA was extracted and reverse transcribed before further analysis
of IFNγ mRNA expression using quantitative PCR. D, PBMCs were pretreated with 20 μg/ml
IgG (vehicle), anti-IFNγ, or anti-IFNγR for 2 h before treatment with 1 ng/ml LPS for 24 h,
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respectively. CD40 expression was determined and expressed as fold over control. *P<0.05,
compared to vehicle LPS.
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